Capricor Therapeutics, Inc.

More coverage

A Rejected Vote Pushes Capricor (CAPR) Toward A Narrower Path

Markets 28 d ago

Capricor Therapeutics stock surges on Oppenheimer upgrade

Markets 30 d ago also on OPY

Capricor Therapeutics stock surges on FDA review extension

Markets 30 d ago 4 sources

Capricor (CAPR) Closed 58% Higher on an FDA Lifeline. Is Approval Really Back on Track?

Markets 35 d ago

Capricor Therapeutics, Inc. (CAPR) Q2 2026 Earnings Call Prepared Remarks Transcript

Earnings 41 d ago 2 sources

Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) with Significant Losses to a Securities Class Action Deadline on September 28, 2026

Deals 43 d ago

Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 28, 2026

Deals 45 d ago

Kaplan Fox Reminds Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on September 28, 2026

Deals 49 d ago